NCT04624009 (NIRS-SCJVO2) is a clinical trial in Impaired Oxygen Delivery, sponsored by University Hospital, Geneva.

Who is sponsoring NCT04624009?

NCT04624009 is sponsored by University Hospital, Geneva.

What condition does NCT04624009 study?

NCT04624009 studies Impaired Oxygen Delivery, Critically Ill Patient.

Is NCT04624009 still recruiting?

NCT04624009 is currently completed. Last updated 29 November 2023.

Last reviewed 2023-11-29 · How we verify

NCT04624009: NIRS-SCJVO2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non-Invasive Measurement of SjvO2 Using Near Infrared Spectroscopy in Critically Ill Patients

Completed Last updated 29 November 2023

What this trial tests

trial in Impaired Oxygen Delivery in 35 participants. Completed in 1 August 2023.

Timeline

1 January 2022

Primary endpoint
1 April 2023

1 August 2023

Quick facts

Lead sponsor	University Hospital, Geneva
Status	Completed
Study type	OBSERVATIONAL
Enrollment	35
Start date	1 January 2022
Primary completion	1 April 2023
Estimated completion	1 August 2023
Sites	2 locations across Switzerland

Conditions studied

Impaired Oxygen Delivery — all drugs for Impaired Oxygen Delivery →
Critically Ill Patient — all drugs for Critically Ill Patient →

Sponsor

University Hospital, Geneva

Who can join

18 and older, any sex, with Impaired Oxygen Delivery or Critically Ill Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

ScvO2 is an important parameter in the management of critically ill patient. The only way to measure it is to have an internal jugular or subclavian central venous catheter. With this trial, the investigators want to show a positive relationship between invasive ScvO2 measurement and noninvasive SjvO2 measurement with VO 100 medical device from Mespere LifeSciences, allowing the use of SjvO2 as a noninvasive surrogate of ScvO2 in critically ill patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Geneva trials

Trials by the same sponsor.

NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
NCT07267624 — EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) · NA · not yet recruiting
NCT06710210 — Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventi · NA · not yet recruiting
NCT07173348 — Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea · NA · not yet recruiting
NCT07129655 — Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Ch · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04624009 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Geneva
Last refreshed: 29 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04624009.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing